ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,431.60
-0.04%
US Tech 100
19,168.00
0.52%
다우존스 지수
38,589.16
-0.15%
Bitcoin
66,475.71
-0.25%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Twist Bioscience Corporation (TWST)

  7. Twist Bioscience Corporation (TWST) 뉴스

TWST

Twist Bioscience (TWST)

Twist Bioscience Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TWST
일자시간출처헤드라인심볼기업
2024/06/1504:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/06/1105:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/06/1105:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/06/1105:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/06/0722:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/06/0704:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/06/0704:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/06/0704:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/06/0704:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/06/0704:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/06/0621:00Business WireTwist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint InhibitorNASDAQ:TWSTTwist Bioscience Corporation
2024/06/0421:00Business WireTwist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI SafetyNASDAQ:TWSTTwist Bioscience Corporation
2024/06/0401:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/2404:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/2321:00Business WireTwist Bioscience to Present at Upcoming Investor ConferencesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/1321:00Business WireTwist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening ApplicationsNASDAQ:TWSTTwist Bioscience Corporation
2024/05/0821:00Business WireTwist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:TWSTTwist Bioscience Corporation
2024/05/0805:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/0805:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/0805:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/05/0305:05Business WireTwist Bioscience Reports Fiscal Second Quarter 2024 Financial ResultsNASDAQ:TWSTTwist Bioscience Corporation
2024/04/1821:00Business WireTwist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024NASDAQ:TWSTTwist Bioscience Corporation
2024/03/2821:00Business WireTwist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse PopulationsNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0906:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0705:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
2024/03/0705:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
 검색 관련기사 보기:NASDAQ:TWST

최근 히스토리

FX
USDEUR
US Dollar vs Euro
NYSE
XOM
Exxon Mobil
NASDAQ
NVDA
NVIDIA
CCOM
SILVER
SILVER
USI
USTECH100
US Tech 100
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLV
Health Care Select Sector
USOTC
ADDYY
Adidas (QX)
NASDAQ
GOOGL
Alphabet
AMEX
XLF
Financial Select Sector
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
FX
USDGBP
US Dollar vs Sterling
NYSE
NKE
Nike
NASDAQ
AMZN
Amazon.com
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유